Abbas, K., S. D. Monaghan, and I. Campbell. Uterine physiology. Anaesth. Intensive Care Med. 12:108–110, 2011.
Abbasi, F., H. Mirzadeh, and A. A. Katbab. Modification of polysiloxane polymers for biomedical applications: a review. Polym. Int. 50:1279–1287, 2001.
Abdul-Aziz, A., Hasham, R. and Abdul Hamid, M. Cosmetics: Polymers in Delivery of Actives. In: Encyclopedia of Polymer Applications, edited by Mishra, M., pp. 743–756; 2018.
Abern, L., and K. Maguire. Contraception knowledge in transgender individuals: are we doing enough? [9F]. Obstet. Gynecol. 131:65S, 2018.
Akindoyo, J. O., et al. Polyurethane types, synthesis and applications—A review. RSC Adv. 6:114453–114482, 2016.
Aldunate, M., et al. Vaginal concentrations of lactic acid potently inactivate HIV. J. Antimicrob. Chemother. 68:2015–2025, 2013.
Allergan. Liletta; 2015.
Amico, J. R., A. H. Bennett, A. Karasz, and M. Gold. She just told me to leave it: women’s experiences discussing early elective IUD removal. Contraception 94:357–361, 2016.
Amico, J. R., A. H. Bennett, A. Karasz, and M. Gold. I wish they could hold on a little longer: physicians’ experiences with requests for early IUD removal. Contraception 96:106–110, 2017.
Apgar, B., and G. Greenberg. Using progestins in clinical practice. Am. Fam. Physician 62:1839–1846, 2000.
Apothecus Pharmaceutical. VCF CA-VAGINAL CONTRACEPTIVE FILM Drug Facts; 1988.
Apothecus Pharmaceutical. VCF CONTRACEPTIVE GEL PRE-FILLED APPLICATORS Drug Facts; 2015.
Aslam, M., M. A. Kalyar, and Z. A. Raza. Polyvinyl alcohol: a review of research status and use of polyvinyl alcohol based nanocomposites. Polym. Eng. Sci. 58:2119–2132, 2018.
Baerwald, A. R., G. P. Adams, and R. A. Pierson. Characterization of ovarian follicular wave dynamics in women. Biol. Reprod. 69:1023–1031, 2003.
Baerwald, A. R., O. A. Olatunbosun, and R. A. Pierson. Effects of oral contraceptives administered at defined stages of ovarian follicular development. Fertil. Steril. 86:27–35, 2006.
Bao, Q., et al. Manufacturing and characterization of long-acting levonorgestrel intrauterine systems. Int. J. Pharm. 550:447–454, 2018.
Barabas, E. S., and C. M. Adeyeye. Crospovidone. Anal. Profiles Drug Subst. Excipients 24:87–163, 1996.
Bardal, S. K., et al. Pharmacokinetics. Appl. Pharmacol. 17–34; 2011.
Barden-O’Fallon, J., I. S. Speizer, L. M. Calhoun, and M. Corroon. Women’s contraceptive discontinuation and switching behavior in urban Senegal, 2010–2015. BMC Womens. Health 18:35, 2018.
Baweja, R., et al. Indian council of medical research tubal sterilization with filshie clip: a multicentre study of the ICMR task force on female sterilization. Contraception 30:339–353, 1984.
Bayer, L. L., and J. T. Jensen. ACIDFORM: a review of the evidence. Contraception 90:11–18, 2014.
Bayer HealthCare Pharmaceuticals. Mirena; 2000.
Bayer HealthCare Pharmaceuticals. Skyla; 2000.
Bayer HealthCare Pharmaceuticals. Kyleena; 2016.
Bayigga, L., D. P. Kateete, D. J. Anderson, M. Sekikubo, and D. Nakanjako. Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention. Am. J. Obstet. Gynecol. 220:155–166, 2019.
Blairex Laboratories. ENCARE- nonoxynol-9 insert; 1999.
Boretos, J. W., and S. J. Boretos. Biomedical Elastomers. In: Handbook of Biomaterial Properties, edited by W. Murphy, J. Black, and G. Hastings. New York: Springer, 2016, pp. 1–676.
Brunner Huber, L. R., et al. Contraceptive use and discontinuation: findings from the contraceptive history, initiation, and choice study. Am. J. Obstet. Gynecol. 194:1290–1295, 2006.
Bulun, S. E. Physiology and Pathology of the Female Reproductive Axis. In: Williams Textbook of Endocrinology, Elsevier, pp. 581–660, 2011.
Caldwell Consumer Health LLC. GYNOL II EXTRA STRENGTH-nonoxynol gel; 2011.
Caldwell Consumer Health LLC. CONCEPTROL OPTIONS-nonoxynol gel Caldwell Cons umer Health LLC; 2011.
Carlson, B. Revolution Contraceptives receives $200K grant from MCI for VasalgelTM development; 2019.
Carrascosa, J. P., et al. The effect of copper on endometrial receptivity and induction of apoptosis on decidualized human endometrial stromal cells. Reprod. Sci. 25:985–999, 2018.
Chan, L. M., and C. L. Westhoff. Tubal sterilization trends in the United States. Fertil. Steril. 94:1–6, 2010.
Chappell, C. A., et al. The effects of reproductive hormones on the physical properties of cervicovaginal fluid. Am. J. Obstet. Gynecol. 211:221–227, 2014.
Chen, Q., S. Liang, and G. A. Thouas. Elastomeric biomaterials for tissue engineering. Prog. Polym. Sci. 38:584–671, 2013.
Cherala, G., A. Edelman, L. Dorflinger, and F. Z. Stanczyk. The elusive minimum threshold concentration of levonorgestrel for contraceptive efficacy. Contraception 94:104–108, 2016.
Cleland, J., A. Conde-Agudelo, H. Peterson, J. Ross, and A. Tsui. Contraception and health. Lancet 380:149–156, 2012.
Conceptus. Summary of Safety and Effectiveness Data: Essure System; 2002.
Cooper, B. G., et al. Friction-lowering capabilities and human subject preferences for a hydrophilic surface coating on latex substrates: implications for increasing condom usage. R. Soc. Open Sci. 5:180291, 2019.
CooperSurgical. ParaGard_FDA; 1988.
Creinin, M. D., S. Keverline, and L. A. Meyn. How regular is regular? An analysis of menstrual cycle regularity. Contraception 70:289–292, 2004.
Daniels, K. and Abma, J. Current Contraceptive Status Among Women Aged 15–49: United States, 2015–2017. NCHS Data Brief; 2018.
da Silva Júnior, W. F., J. G. Deoliveira Pinheiro, C. D. L. F. A. Moreira, F. deSouza, and A. A. N. deLima. Alternative technologies to improve solubility and stability of poorly water-soluble drugs. Multifunct. Syst. Comb. Deliv. Biosensing Diagnostics 1:281–305, 2017.
das Neves, J., and M. F. Bahia. Gels as vaginal drug delivery systems. Int. J. Pharm. 318:1–14, 2006.
Dinh, A., I. Sriprasert, A. R. Williams, and D. F. Archer. A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women. Contraception 91:360–367, 2015.
Diniz, S. G., A. F. P. L. d’Oliveira, and S. Lansky. Equity and women’s health services for contraception, abortion and childbirth in Brazil. Reprod. Health Matters 20:94–101, 2012.
Dziuk, P. J., and B. Cook. Passage of steroids through silicone rubber. Endocrinology 78:208–211, 1966.
Eschenbach, D., et al. Influence of the normal menstrual cycle on vaginal microflora. Clin. Infect. Dis. 32:325, 2002.
Evofem Biosciences Inc. Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study Evaluating Amphora for Hormone-Free Birth Control; 2018.
Ewies, A. A. A. Levonorgestrel-releasing intrauterine system—The discontinuing story. Gynecol. Endocrinol. 25:668–673, 2009.
FemCap. Summary of Safety and Effectiveness Data: FemCap; 2003.
Fu, Y., and W. J. Kao. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin. Drug Deliv. 7:429–444, 2010.
Gadella, B. M. Sperm membrane physiology and relevance for fertilization. Anim. Reprod. Sci. 107:229–236, 2008.
Gallo, M. F., D. A. Grimes, L. M. Lopez, and K. F. Schulz. Nonlatex versus latex male condoms for contraception. Rev: Cochrane Database Syst, 2006.
Galzote, R. M., S. Rafie, R. Teal, and S. K. Mody. Transdermal delivery of combined hormonal contraception: a review of the current literature. Int. J. Womens. Health 9:315–321, 2017.
Garbarczyk, M., W. Kuhn, J. Klinowski, and S. Jurga. Characterization of aged nitrile rubber elastomers by NMR spectroscopy and microimaging. Polymer (Guildf). 43:3169–3172, 2002.
Garcia, C., et al. Salpingectomy compared with tubal ligation at cesarean delivery a randomized controlled trial. Obstet. Gynecol. 132:29–34, 2018.
Garcia, F. A., B. Barker, T. Myloyde, P. Blumenthal, and G. R. Huggins. The Filshie clip for laparoscopic adnexal surgery. JSLS 5:179–181, 2001.
Gipson, I. K., et al. The amount of MUC5B mucin in cervical mucus peaks at midcycle. J. Clin. Endocrinol. Metab. 86:594–600, 2001.
Gondos, B. Histologic changes associated with oral contraceptive usage. Ann. Clin. Lab. Sci. 6:291–299, 1976.
Gupta, S., and V. Prabha. Intravaginal delivery approaches for contraception: an overview with emphasis on gels. J. Pharm. Pharm. Sci. 20:270–284, 2017.
Han, L., R. Taub, and J. T. Jensen. Cervical mucus and contraception: what we know and what we don’t. Contraception 96:310–321, 2017.
Hannon, P. R., and J. A. Flaws. The effects of phthalates on the ovary. Front. Endocrinol. 6:8, 2015.
Hapangama, D. K., and J. N. Bulmer. Pathophysiology of heavy menstrual bleeding. Women’s Health 12:3–13, 2016.
Hepburn, C. Polyurethane Elastomers. New York: Springer, 2012.
Hiorth, M., S. Nilsen, and I. Tho. Bioadhesive mini-tablets for vaginal drug delivery. Pharmaceutics 6:494–511, 2014.
Holesh, J., and M. Lord. Physiology, Ovulation. Treasure Island: StatPearls Publishing, 2017.
Hopkins, M., and C. Lessard. Efficacy, safety, and patient acceptability of the EssureTM; procedure. Patient Prefer. Adherence 5:207, 2011.
Howard, B., E. Grubb, M. J. Lage, and B. Tang. Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion. Reprod. Health 14:70, 2017.
Hubacher, D., P. L. Chen, and S. Park. Side effects from the copper IUD: do they decrease over time? Contraception 79:356–362, 2009.
Hussain, A., and F. Ahsan. The vagina as a route for systemic drug delivery. J. Control. Release 103:301–313, 2005.
Hwang, W.-G., K.-H. Wei, and C.-M. Wu. Preparation and mechanical properties of nitrile butadiene rubber/silicate nanocomposites. Polymer (Guildf). 45:5729–5734, 2004.
Ismail, N., N. Giribabu, S. Muniandy, and N. Salleh. Estrogen and progesterone differentially regulate the levels of cystic fibrosis transmembrane regulator (CFTR), adenylate cyclase (AC), and cyclic adenosine mono-phosphate (cAMP) in the rat cervix. Mol. Reprod. Dev. 82:463–474, 2015.
Johnston, D. CRB Funded Projects; 2017.
Juliano, C., E. Gavini, M. Cossu, M. C. Bonferoni, and P. Giunchedi. Mucoadhesive alginate matrices containing sodium carboxymethyl starch for buccal delivery: in vitro and in vivo studies. J. Drug Deliv. Sci. Technol. 14:159–163, 2004.
Kalamar, A. M., Ö. Tunçalp, and M. J. Hindin. Developing strategies to address contraceptive needs of adolescents: exploring patterns of use among sexually active adolescents in 46 low- and middle-income countries. Contraception 98:36–40, 2018.
Kaliyathan, A., A. Mathew, A. Rane, K. Kanny, and S. Thomas. Natural rubber and silicone rubber-based biomaterials. In: Fundamental Biomaterials: Polymers, edited by S. Thomas, P. Balakrishnan, and M. S. Sreekala. Sawston: Woodhead Publishing, 2018, pp. 71–84.
Kaneko, J. J., Harvey, J. W., Bruss, M. L. and Andersson, H. Clinical reproductive endocrinology. Clin. Biochem. Domest. Anim. 635–662; 2008.
Karande, P., and S. Mitragotri. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim. Biophys. Acta - Biomembr. 1788:2362–2373, 2009.
Kariduraganavar, M. Y., Kittur, A. A. and Kamble, R. R. Polymer Synthesis and Processing. Nat. Synth. Biomed. Polym. 1–31, 2014.
Kavanaugh, M. L., and J. Jerman. Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014. Contraception 97:14–21, 2018.
Keller, M. J., et al. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive. PLoS One 7:46901, 2012.
Kessel. Caya contoured Diaphragm; 2014.
Khourdaji, I., J. Zillioux, K. Eisenfrats, D. Foley, and R. Smith. The future of male contraception: A fertile ground. Transl. Androl. Urol. 7:S220–S235, 2018.
Kotz, D. FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information. FDA News Release; 2018.
Kux, L. Obstetrical and Gynecological Devices; Reclassification of Single-Use Female Condom, To Be Renamed Single-Use Internal Condom; 2018.
Labidi-Galy, S. I., et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8:1093, 2017.
Lai, B. E., et al. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow. J. Pharm. Sci. 97:1030–1038, 2008.
Leahy, T., and B. M. Gadella. Sperm surface changes and physiological consequences induced by sperm handling and storage. Reproduction 142:759–778, 2011.
Leese, H., J. I. Tay, and S. Downing. Formation of Fallopian tubal fluid: role of a neglected epithelium. Reproduction 121:339–346, 2001.
Li, W., et al. Rapidly separable microneedle patch for the sustained release of a contraceptive. Nat. Biomed. Eng. 3:220–229, 2019.
Lohiya, N. K., et al. Preclinical evaluation for noninvasive reversal following long-term vas occlusion with styrene maleic anhydride in langur monkeys. Contraception 71:214–226, 2005.
Lohiya, N. K., I. Alam, M. Hussain, S. R. Khan, and A. S. Ansari. RISUG: an intravasal injectable male contraceptive. Indian J. Med. Res. 140(Suppl):S63–S72, 2014.
Lähteenmäki, P., I. Rauramo, and T. Backman. The levonorgestrel intrauterine system in contraception. Steroids 65:693–697, 2000.
Lüthje, P., A. Lindén Hirschberg, and A. Brauner. Estrogenic action on innate defense mechanisms in the urinary tract. Maturitas 77:32–36, 2014.
Mack, N., et al. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception. Cochrane Database Syst. Rev; 2019.
Malcolm, K., et al. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings. J. Control. Release 90:217–225, 2003.
Maslyanskaya, S., S. M. Coupey, R. Chhabra, and U. I. Khan. Predictors of early discontinuation of effective contraception by teens at high risk of pregnancy. J. Pediatr. Adolesc. Gynecol. 29:269–275, 2016.
Mayer Laboratories. TODAY Contraceptive Sponge; 2005.
McCluggage, W. G. Benign diseases of the endometrium. In: Blaustein’s Pathology of the Female Genital Tract, edited by R. J. Kurman, L. H. Ellenson, and B. M. Ronnett. US: Springer, 2011, pp. 305–358.
McDermott, M. K., et al. Mechanical properties of polyurethane film exposed to solutions of nonoxynol-9 surfactant and poly(ethylene glycol). J. Appl. Polym. Sci. 91:1086–1096, 2004.
McKeen, L. ‘Elastomers’. In: The Effect of Sterilization on Plastics and Elastomers. William Andrew Publishing, pp. 319–353, 2012.
Medicines360. Medicines360, Afaxys Partner to Expand Public Health Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg; 2018.
Merck & Co. Nuvaring_FDA; 2001.
Michaelis, M., and C. S. Leopold. Mixture design approach for early stage formulation development of a transdermal delivery system. Drug Dev. Ind. Pharm. 41:1532–1540, 2015.
Miranda, M. C. R., et al. Evaluation of peptides release using a natural rubber latex biomembrane as a carrier. Amino Acids 50:503–511, 2018.
Moreau, C., K. Cleland, and J. Trussell. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception 76:267–272, 2007.
Murdoch, F. E., and E. Goldberg. Male contraception: another holy grail. Bioorg. Med. Chem. Lett. 24:419–424, 2014.
Musah, R. A., A. L. Vuong, C. Henck, and J. R. E. Shepard. Detection of the spermicide nonoxynol-9 via GC-MS. J. Am. Soc. Mass Spectrom. 23:996–999, 2012.
Mylan Pharmaceuticals Inc. XULANE; 2014.
OpenStax. ‘Hormonal Control of Human Reproduction’. In: Biology, edited by CNX Biology OpenStax CNX, 2015.
OpenStax. Anatomy and Physiology of the Male Reproductive System. In: Anatomy and Physiology, OpenStax CNX, 2016.
OpenStax. ‘Anatomy and Physiology of the Female Reproductive System’. In: Anatomy & Physiology, OpenStax CNX, 2016.
Ortiz, M. E., H. B. Croxatto, and C. W. Bardin. Mechanisms of action of intrauterine devices. Obstet. Gynecol. Surv. 51:42–51, 1996.
Osman, A. F., A. M. Alakrach, H. Kalo, W. N. W. Azmi, and F. Hashim. In vitro biostability and biocompatibility of ethyl vinyl acetate (EVA) nanocomposites for biomedical applications. RSC Adv. 5:31485–31495, 2015.
Owen, D. H., J. J. Peters, and D. F. Katz. Rheological properties of contraceptive gels. Contraception 62:321–326, 2000.
Paik, D. Y., et al. Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation. Stem Cells 30:2487–2497, 2012.
Park, C. J., et al. Sanitary pads and diapers contain higher phthalate contents than those in common commercial plastic products. Reprod. Toxicol. 84:114–121, 2019.
Pastore, M. N., Y. N. Kalia, M. Horstmann, and M. S. Roberts. Transdermal patches: history, development and pharmacology. Br. J. Pharmacol. 172:2179–2209, 2015.
Patai, K. Local tissue effects of copper-containing intrauterine devices. Fertil. Steril. 80:1281–1283, 2003.
Patel, H. B., G. J. P. Fleming, and F. J. T. Burke. Puncture resistance and stiffness of nitrile and latex dental examination gloves. Br. Dent. J. 196:695, 2004.
Prasad, K., et al. Metallic biomaterials: current challenges and opportunities. Materials 10:884, 2017.
Prior, J. C., M. Naess, A. Langhammer, and S. Forsmo. Ovulation prevalence in women with spontaneous normal-length menstrual cycles—A population-based cohort from HUNT3 ,Norway. PLoS ONE 10:0134473, 2015.
Pymar, H. C., M. D. Creinin, and M. C. Vallejo. Prospective randomized, controlled study of postoperative pain after titanium silicone rubber clip or Silastic ring tubal occlusion. Contraception 69:145–150, 2004.
Rego, A., and L. Roley. In-use barrier integrity of gloves: latex and nitrile superior to vinyl. Am. J. Infect. Control 27:405–410, 1999.
Richardson, J., and T. Armstrong. Vaginal delivery of calcitonin by hyaluronic acid formulations. In: Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and Developments, edited by E. Mathiowitz, D. E. Chickering III, and C.-M. Lehr. Boca Raton: CRC Press, 1999, pp. 565–570.
Rivera, R., I. Yacobson, and D. Grimes. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am. J. Obstet. Gynecol. 181:1263–1269, 1999.
Roblero, L., A. Guadarrama, T. Lopez, and F. Zegers-Hochschild. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro. Reprod. Fertil. Dev. 8:871–874, 1996.
Rose, S., A. Chaudhari, and C. M. Peterson. Mirena® (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception. Adv. Drug Deliv. Rev. 61:808–812, 2009.
Roumen, F. J. Review of the combined contraceptive vaginal ring, NuvaRing ®. Ther. Clin. Risk Manag. 4:441–451, 2008.
Rowley, J., et al. Global and Regional Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2016. WHO Bulletin, 2019.
Saldanha, N. Use of short acting reversible contraception in adolescents: the pill, patch, ring and emergency contraception. Curr. Probl. Pediatr. Adolesc. Health Care 48:333–344, 2018.
Samavedi, S., Poindexter, L. K., Van Dyke, M. and Goldstein, A. S. Synthetic biomaterials for regenerative medicine applications. Regen. Med. Appl. Organ Transplant. 81–99; 2014.
Schneider, C., R. Langer, D. Loveday, and D. Hair. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems. J. Control. Release 262:284–295, 2017.
Schreiber, C. A., S. J. Ratcliffe, M. D. Sammel, and P. G. Whittaker. A self-assessment efficacy tool for spermicide contraceptive users. Am. J. Obstet. Gynecol. 214(264):e1–264.e7, 2016.
Seymour, R. B., and G. B. Kauffman. Polyurethanes: a class of modern versatile materials. J. Chem. Educ. 69:909, 2009.
Shastri, P. V. Toxicology of polymers for implant contraceptives for women. Contraception 65:9–13, 2002.
Sitruk-Ware, R. Routes of delivery for progesterone and progestins. Maturitas 57:77–80, 2007.
Sitruk-Ware, R., A. Nath, and D. R. Mishell. Contraception technology: past, present and future. Contraception 87:319–330, 2013.
Sivin, I. IUDs are contraceptives, not abortifacients: a comment on research and belief. Stud. Fam. Plann. 20:355, 2006.
Sokal, D., D. Gates, R. Amatya, and R. Dominik. Two randomized controlled trials comparing the Tubal Ring and Filshie Clip for tubal sterilization. Fertil. Steril. 74:525–533, 2000.
Srakaew, N., et al. Antimicrobial host defence peptide, LL-37, as a potential vaginal contraceptive. Hum. Reprod. 29:683–696, 2014.
Stanford, J. B., and R. T. Mikolajczyk. Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am. J. Obstet. Gynecol. 187:1699–1708, 2002.
Stuart, J. E., G. M. Secura, Q. Zhao, M. E. Pittman, and J. F. Peipert. Factors associated with 12-month discontinuation among contraceptive pill, patch, and ring users. Obstet. Gynecol. 121:330–336, 2013.
Suarez, S. S., and A. A. Pacey. Sperm transport in the female reproductive tract. Hum. Reprod. Update 12:23–37, 2006.
Subramaniam, A., et al. Feasibility of complete salpingectomy compared with standard postpartum tubal ligation at cesarean delivery a randomized controlled trial. Obstet. Gynecol. 132:20–27, 2018.
Tan, H. S., and W. R. Pfister. Pressure-sensitive adhesives for transdermal drug delivery systems. Pharm. Sci. Technol. Today 2:60–69, 1999.
Tanphaichitr, N., et al. Potential use of antimicrobial peptides as vaginal spermicides/microbicides. Pharmaceuticals 9:13, 2016.
The Female Health Company. Summary of Safety and Effectiveness Data: FC2; 2009.
Tibaijuka, L., et al. Factors influencing use of long-acting versus short-acting contraceptive methods among reproductive-age women in a resource-limited setting. BMC Womens. Health 17:25, 2017.
Trussell, J. Contraceptive failure in the United States. Contraception 83:397–404, 2011.
Trussell, J., and B. Vaughan. Contraceptive failure, method-related discontinuation and resumption of Use: results from the 1995 National Survey of Family Growth. Fam. Plan. Perspect. 31:64–72, 1999.
Valle, R. F., C. S. Carignan, and T. C. Wright. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil. Steril. 76:974–980, 2001.
Van Damme, L., et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 360:971–977, 2002.
Vitzthum, V. J., and K. Ringheim. Hormonal contraception and physiology: a research-based theory of discontinuation due to side effects. Stud. Fam. Plann. 36:13–32, 2005.
Wallach, E. E., H. J. Tatum, and E. B. Connell-Tatum. Barrier contraception: a comprehensive overview. Fertil. Steril. 36:1–12, 2016.
Waller, D., D. Bolick, E. Lissner, C. Premanandan, and G. Gamerman. Reversibility of VasalgelTM male contraceptive in a rabbit model. Basic Clin. Androl. 27:8, 2017.
Wieder, D. R., and L. Pattimakiel. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (nuvaring®). Int. J. Womens. Health 2:401–409, 2010.
Williams, T. D. Individual variation in endocrine systems: moving beyond the ‘tyranny of the Golden Mean’. Philos. Trans. R. Soc. B 363:1687–1698, 2008.
Winner, B., et al. Effectiveness of long-acting reversible contraception. N. Engl. J. Med. 366:1998–2007, 2012.
World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. Cambridge University Press; 1992.
World Health Organization. Family Planning and Contraception. 2018.
World Health Organization. Report on global sexually transmitted infection surveillance 2018, 2018.
Young, J. M., and A. S. McNeilly. Theca: the forgotten cell of the ovarian follicle. Reproduction 140:489–504, 2010.
Zavos, P. M., J. R. Correa, D. Nosek, F. Mohammadi, and G. A. Digenis. Assessment of new formulations of nonoxynol-9 coprecipitated with polyvinylpyrrolidone and iodine as possible vaginal contraceptives. Fertil. Steril. 66:729–733, 2016.
Zini, A. Vasectomy update 2010. Can. Urol. Assoc. J. 4:306–309, 2010.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4